NATR
NATURES SUNSHINE PRODUCTS INC
Pharmaceutical PreparationsNasdaqAccelerated filer<br>Smaller reporting company
Total Trades
25
Buys
6
Sells
17
Largest Trade
$1M+
Insiders
6
Institutional Funds
106
Inst. Value
$1M+
Activist Filings
7
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Yates Bryant J | EVP & President | SELL | $15K–$50K | 2K | $22.29 | Dec 16, 2025 |
| Norman Daniel C | EVP & President | SELL | $100K–$500K | 9K | $20.46 | Nov 19, 2025 |
| Lanoy Jonathan David | SVP | SELL | $100K–$500K | 5K | $20.45 | Nov 19, 2025 |
| Brower Nathan G | EVP, General Counsel | SELL | $50K–$100K | 4K | $20.81 | Nov 18, 2025 |
| Yates Bryant J | EVP & President | SELL | $100K–$500K | 10K | $16.74 | Sep 4, 2025 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | SELL | $1M+ | 2.9M | $11.46 | Jun 27, 2025 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | SELL | $15K–$50K | 2K | $13.02 | Oct 17, 2024 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10% Owner | SELL | $100K–$500K | 11K | $13.33 | Oct 15, 2024 |
| Yates Bryant J | EVP & President | SELL | $15K–$50K | 3K | $15.30 | Jun 24, 2024 |
| Norman Daniel C | EVP & President | SELL | $100K–$500K | 15K | $17.13 | Dec 1, 2023 |
| Brower Nathan G | EVP, General Counsel | SELL | $50K–$100K | 4K | $17.31 | Nov 27, 2023 |
| Yates Bryant J | EVP & President | EXERCISE | $100K–$500K | 15K | $13.88 | Aug 31, 2023 |
| Yates Bryant J | EVP & President | SELL | $100K–$500K | 15K | $16.77 | Aug 31, 2023 |
| Norman Daniel C | EVP & President | EXERCISE | $100K–$500K | 12K | $13.88 | Aug 29, 2023 |
| Norman Daniel C | EVP & President | SELL | $100K–$500K | 12K | $16.40 | Aug 29, 2023 |
| Yates Bryant J | EVP & President | SELL | $100K–$500K | 9K | $11.63 | Jun 22, 2023 |
| Norman Daniel C | EVP & President | SELL | $100K–$500K | 15K | $11.18 | Jun 21, 2023 |
| Brower Nathan G | EVP, General Counsel | SELL | $100K–$500K | 11K | $10.97 | Jun 1, 2023 |
| Brower Nathan G | EVP, General Counsel | SELL | $15K–$50K | 5K | $8.18 | Dec 14, 2022 |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 10% Owner | BUY | $15K–$50K | 5K | $8.93 | Sep 19, 2022 |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 10% Owner | BUY | $15K–$50K | 4K | $9.30 | Sep 12, 2022 |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 10% Owner | BUY | $50K–$100K | 9K | $9.51 | Sep 6, 2022 |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 10% Owner | BUY | $100K–$500K | 11K | $9.63 | Aug 31, 2022 |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 10% Owner | BUY | $100K–$500K | 38K | $9.71 | Aug 29, 2022 |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 10% Owner | BUY | $50K–$100K | 7K | $9.99 | Aug 25, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 106 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| WYNNEFIELD CAPITAL INC | 2.5M | $1M+ | SH |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 1.8M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 847K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 676K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 631K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 524K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 455K | $1M+ | SH |
| STATE STREET CORP | 316K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 311K | $1M+ | SH |
| Hillsdale Investment Management Inc. | 219K | $1M+ | SH |
| Skylands Capital, LLC | 181K | $1M+ | SH |
| CSM Advisors, LLC | 147K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 134K | $1M+ | SH |
| BlackRock, Inc. | 114K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 107K | $1M+ | SH |
| First Eagle Investment Management, LLC | 99K | $1M+ | SH |
| MORGAN STANLEY | 91K | $1M+ | SH |
| LAZARD ASSET MANAGEMENT LLC | 90K | $1M+ | SH |
| MACKENZIE FINANCIAL CORP | 86K | $1M+ | SH |
| North Star Investment Management Corp. | 75K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Oct 17, 2025
5.0%
890K shares
SC 13G · Oct 9, 2025
5.2%
914K shares
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SC 13D/A · Jun 27, 2025
0.3%
64K shares
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SC 13D/A · Jun 9, 2025
15.9%
2.9M shares
(s) (entities only) Paradigm Capital Management, Inc. 14-1770168
SC 13G/A · Feb 12, 2024
2.9%
548K shares
Prescott Group Capital Management, L.L.C.
SC 13G/A · Jan 31, 2024
9.4%
1.8M shares
(s) (entities only) Paradigm Capital Management, Inc. 14-1770168
SC 13G/A · Feb 13, 2023
5.9%
1.1M shares